These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 21130700)

  • 1. Bilateral Coats' response in a female patient leads to diagnosis of facioscapulohumeral muscular dystrophy.
    Bass SJ; Sherman J; Giovinazzo V
    Optometry; 2011 Feb; 82(2):72-6. PubMed ID: 21130700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subclinical facioscapulohumeral muscular dystrophy masquerading as bilateral Coats disease in a woman.
    Vance SK; Wald KJ; Sherman J; Freund KB
    Arch Ophthalmol; 2011 Jun; 129(6):807-9. PubMed ID: 21670353
    [No Abstract]   [Full Text] [Related]  

  • 3. Coats-like retinopathy in an infant with preclinical facioscapulohumeral dystrophy.
    Ganesh A; Kaliki S; Shields CL
    J AAPOS; 2012 Apr; 16(2):204-6. PubMed ID: 22525183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular tortuosity and Coats'-like retinal changes in facioscapulohumeral muscular dystrophy.
    Tekin NF; Saatci AO; Kavukçu S
    Ophthalmic Surg Lasers; 2000; 31(1):82-3. PubMed ID: 10976570
    [No Abstract]   [Full Text] [Related]  

  • 5. Diagnostic challenges in facioscapulohumeral muscular dystrophy.
    Sacconi S; Salviati L; Bourget I; Figarella D; Péréon Y; Lemmers R; van der Maarel S; Desnuelle C
    Neurology; 2006 Oct; 67(8):1464-6. PubMed ID: 17060574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid and accurate diagnosis of facioscapulohumeral muscular dystrophy.
    Goto K; Nishino I; Hayashi YK
    Neuromuscul Disord; 2006 Apr; 16(4):256-61. PubMed ID: 16545566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coats' disease associated with muscular dystrophy treated with ranibizumab.
    Diago T; Valls B; Pulido JS
    Eye (Lond); 2010 Jul; 24(7):1295-6. PubMed ID: 20075964
    [No Abstract]   [Full Text] [Related]  

  • 8. Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy.
    Osborne RJ; Welle S; Venance SL; Thornton CA; Tawil R
    Neurology; 2007 Feb; 68(8):569-77. PubMed ID: 17151338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bilateral fluorescein angiographic findings in unilateral Coats' disease.
    Shane TS; Berrocal AM; Hess DJ
    Ophthalmic Surg Lasers Imaging; 2011 Feb; 42 Online():e15-7. PubMed ID: 21323189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe phenotype in infantile facioscapulohumeral muscular dystrophy.
    Klinge L; Eagle M; Haggerty ID; Roberts CE; Straub V; Bushby KM
    Neuromuscul Disord; 2006 Oct; 16(9-10):553-8. PubMed ID: 16934468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinal telangiectasis detected during a vision screening examination in a child with hearing loss led to the diagnosis of facioscapulohumeral muscular dystrophy.
    Lee GD; Chen VM; Barnes AC; Goldman DR; Duker JS
    J AAPOS; 2014 Jun; 18(3):303-5. PubMed ID: 24924285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical facet of Möbius syndrome: association with facioscapulohumeral muscular dystrophy.
    Kolski HK; Leonard NJ; Lemmers RJ; Bamforth JS
    Muscle Nerve; 2008 Apr; 37(4):526-9. PubMed ID: 18059038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular diagnosis of facioscapulohumeral muscular dystrophy.
    Upadhyaya M; Cooper DN
    Expert Rev Mol Diagn; 2002 Mar; 2(2):160-71. PubMed ID: 11962336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe fascioscapulohumeral muscular dystrophy presenting with Coats' disease and mental retardation.
    Bindoff LA; Mjellem N; Sommerfelt K; Krossnes BK; Roberts F; Krohn J; Tranheim RS; Haggerty ID
    Neuromuscul Disord; 2006 Oct; 16(9-10):559-63. PubMed ID: 16935506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymptomatic elevation of serum creatine kinase leading to the diagnosis of 4q35 facioscapulohumeral muscular dystrophy.
    Zouvelou V; Manta P; Kalfakis N; Evdokimidis I; Vassilopoulos D
    J Clin Neurosci; 2009 Sep; 16(9):1218-9. PubMed ID: 19502063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular findings and treatment of a young boy with Coats’ plus.
    Yannuzzi NA; Tzu JH; Ko AC; Hess DJ; Cristian I; Berrocal AM
    Ophthalmic Surg Lasers Imaging Retina; 2014; 45(5):462-5. PubMed ID: 25197929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coats syndrome in facioscapulohumeral dystrophy type 1: frequency and D4Z4 contraction size.
    Statland JM; Sacconi S; Farmakidis C; Donlin-Smith CM; Chung M; Tawil R
    Neurology; 2013 Mar; 80(13):1247-50. PubMed ID: 23446679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous resolution of retinal vascular abnormalities and macular oedema in facioscapulohumeral muscular dystrophy.
    Lindner M; Holz FG; Charbel Issa P
    Clin Exp Ophthalmol; 2016 Sep; 44(7):627-628. PubMed ID: 26933772
    [No Abstract]   [Full Text] [Related]  

  • 19. Prenatal diagnosis for facioscapulohumeral muscular dystrophy (FSHD).
    Upadhyaya M; MacDonald M; Ravine D
    Prenat Diagn; 1999 Oct; 19(10):959-65. PubMed ID: 10521823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testing the position-effect variegation hypothesis for facioscapulohumeral muscular dystrophy by analysis of histone modification and gene expression in subtelomeric 4q.
    Jiang G; Yang F; van Overveld PG; Vedanarayanan V; van der Maarel S; Ehrlich M
    Hum Mol Genet; 2003 Nov; 12(22):2909-21. PubMed ID: 14506132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.